For only being in preclinical stage, its about right IMO. They will need to raise funds in the not too distant future to fund Ph 1 and 2, so sizable dilution is coming.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.